Le Lézard
Classified in: Ebola virus

Global Incontinence Devices and Ostomy Market 2020-2025 - ResearchAndMarkets.com


The "Global Incontinence Devices and Ostomy Market 2020-2025" report has been added to ResearchAndMarkets.com's offering.

The global incontinence devices and ostomy market is expected to register a CAGR of nearly 10.1%, during the forecast period.

Certain factors that are driving the market growth include the rising geriatric and obese populations, increasing prevalence of renal diseases and nephrological injuries, and growing awareness and acceptance regarding ostomy care products. Adult diapers are significantly necessary in cases that involve mobility impairment, severe diarrhoea, or dementia.

Decreased renal function, primarily age-related, is one of the major indicators of chronic diseases. This may be accelerated, due to several other chronic diseases, such as hypertension, diabetes, and obesity, among other diseases, often leading to different stages of kidney diseases.

These diseases are health burdens, globally, with high economic costs to healthcare systems. As per the WHO's Integrated Care for Older People (ICOPE) Guidelines and specific population-based studies released in 2017, the global prevalence of UI was observed to be in the range of 8.9%-36.1%, in different patient pools.

Key Market Trends

Colorectal Cancer is Expected to Observe Lucrative Growth in the Application Segment

North America Dominates the Market, and is Expected to do the Same during the Forecast Period

Competitive Landscape

The incontinence devices and ostomy market is highly competitive and consists of a number of major players. Companies, like Abena AS, B. Braun Melsungen AG, Coloplast Corporation, ConvaTec, Hollister Inc., Kimberly-Clark Corporation, Salts Healthcare, SCA (Svenska Cellulosa Aktiebolaget), and Unicharm Corporation, among others, hold substantial shares in the market.

Key Topics Covered

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Rising Geriatric and Obese Populations

4.2.2 Increasing Prevalence of Renal Diseases and Nephrological Injuries

4.2.3 Growing Awareness and Acceptance Regarding Ostomy Care Products

4.3 Market Restraints

4.3.1 Lack of Proper Reimbursement

4.3.2 Complications Associated with Ostomy and Usage of Incontinence Products

4.4 Porter's Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 Product Type

5.1.1 Incontinence Care Products

5.1.1.1 Absorbents

5.1.1.2 Incontinence Bags

5.1.1.3 Other Product Types (Clamps, Deodorizers, Cleaners, Urinals, etc.)

5.1.2 Ostomy Care Products

5.1.2.1 Ostomy Bags

5.1.2.1.1 Colostomy Bags

5.1.2.1.2 Ileostomy Bags

5.1.2.1.3 Urostomy Bags

5.1.2.2 Skin Barriers

5.1.2.3 Irrigation Products

5.1.2.4 Other Ostomy Products

5.2 Application

5.2.1 Bladder Cancer

5.2.2 Colorectal Cancer

5.2.3 Crohn's Disease

5.2.4 Kidney Stone

5.2.5 Chronic Kidney Failure

5.2.6 Other Applications

5.3 Geography

5.3.1 North America

5.3.2 Europe

5.3.3 Asia-Pacific

5.3.4 Middle-East & Africa

5.3.5 South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Abena AS

6.1.2 B. Braun Melsungen AG

6.1.3 Coloplast Corporation

6.1.4 ConvaTec

6.1.5 Hollister Inc.

6.1.6 Kimberly-Clark Corporation

6.1.7 Salts Healthcare

6.1.8 Unicharm Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/ep5qmd


These press releases may also interest you

21 mar 2019
The "Europe Welding Equipment Market-Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. Welding is one of the critical processes employed in the manufacturing...

21 mar 2019
Inovio Pharmaceuticals, Inc. announced today that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses. This Phase 1 data was published in The Journal of Infectious Diseases and further supports the...

20 mar 2019
Merck , known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has exercised its option to extend the research phase of the companies' broad, strategic collaboration...

20 mar 2019
The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Monday, 29 April 2019 at 3:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden. RIGHT TO PARTICIPATE AND NOTICE Shareholders who wish to...

20 mar 2019
The Oslo Business for Peace Award is given to inspiring business leaders who have put society first. 2019's winners are: Dr Agbor Ashumanyi Ako, medical director of GiftedMom, Alice Laugher, CEO of Committed to...

19 mar 2019
The evolving competitive market has made it essential for the telecommunication industry to rethink traditional ways of doing business in terms of the impact on business models, service portfolios and technical architectures. Digital business support...



News published on and distributed by: